Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-07-18

FDA Approved: ZIAGEN — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

The FDA approved a supplemental application for ZIAGEN (abacavir sulfate) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ziagen (Abacavir)

Snippet

SUPPL AP for ZIAGEN (ABACAVIR SULFATE)